Related by context. All words. (Click for frequent words.) 80 pegylated interferon 79 ribavirin RBV 76 peginterferon 75 peginterferon alfa 2a 75 pegylated interferon alpha 75 Peg IFN 75 peginterferon alfa 2b 73 ribavirin therapy 73 dacarbazine 72 peg IFN 72 Pegasys ® 72 pegylated interferon alfa 2a 72 alfa 2a 71 pegylated interferon alfa 71 ribavirin 71 mcg kg 71 peg interferon 71 chlorambucil 71 lopinavir r 70 FOLFIRI 70 PegIFN RBV 70 peginterferon alfa 2a #KD 70 ritonavir boosted 70 docetaxel chemotherapy 70 plus dexamethasone 70 FOLFOX 69 LEXIVA r 69 daily Infergen 69 LPV r 69 interferon alfa 2b 69 abacavir lamivudine 69 nab paclitaxel 69 pegylated interferon alpha 2a 69 lamivudine 69 interferon alfa 2a 69 Pegasys plus Copegus 69 docetaxel 69 ACTEMRA TM 69 8mg/kg 69 APTIVUS r 69 viral kinetics 69 PegIFN 69 plus prednisone 68 #mg QD [002] 68 adalimumab 68 HCV genotype 1 68 subcutaneously administered 68 PEG interferon 68 interferon alfa 68 mg QD 68 active comparator 68 pegylated interferon alfa 2b 68 administered subcutaneously 68 alpha 2a 67 PREZISTA r 67 celgosivir 67 darunavir ritonavir 67 4mg/kg 67 VELCADE melphalan 67 sustained virologic response 67 FOLFOX4 67 peginterferon alfa 67 interferon ribavirin 67 mg qd 67 CIMZIA TM 67 #mg/m# [002] 67 amoxicillin clavulanate 67 oral rivaroxaban 67 tipranavir 67 bendamustine 67 certolizumab 66 pegylated interferon peg IFN 66 plus COPEGUS 66 nitazoxanide 66 CANCIDAS 66 pegylated alpha interferon 66 fluticasone 66 Fludara 66 5-FU/LV 66 REBETOL 66 fluticasone salmeterol 66 Peginterferon 66 mg kg dose 66 PREZISTA ritonavir 66 mcg albinterferon alfa 2b 66 Ribavirin 66 atazanavir ritonavir 66 PEGINTRON TM 66 PEG Intron 66 mg ustekinumab 66 ug kg 66 monotherapy 66 Copegus ribavirin 66 naïve HCV 66 daunorubicin 66 azathioprine 66 docetaxel Taxotere ® 66 carboplatin paclitaxel 66 APTIVUS 66 salmeterol fluticasone 66 saline placebo 66 DAPT 66 idarubicin 65 ABC/3TC 65 alpha 2b 65 Taxotere ® 65 peginterferon alpha 2a 65 telaprevir dosed 65 adjunctive placebo 65 μg dose 65 Aptivus ® 65 ritonavir boosted atazanavir 65 boosted protease inhibitor 65 mg TID 65 tiotropium 65 irbesartan 65 entecavir 65 sustained virological response 65 HCV RESPOND 2 65 lamivudine refractory patients 65 mg RDEA# 65 PegIntron 65 Pegasys R 65 sunitinib 65 IFN α 65 HBeAg positive patients 65 ULORIC 65 rizatriptan 65 mcg dose 65 protease inhibitor PI 65 lispro 65 lopinavir ritonavir 65 Peginterferon alfa 2a 65 dexamethasone 65 SVR# 65 azacitidine 65 decitabine 65 PEG IFN 65 adefovir 65 gemcitabine 65 #mg/day [002] 64 posaconazole 64 mitoxantrone 64 mg BID 64 Doxil ® 64 pegylated liposomal doxorubicin 64 QD dosing 64 linezolid 64 achieve sustained virologic 64 Flu Cy 64 vinorelbine 64 5FU 64 dasatinib Sprycel ® 64 microbiological eradication 64 COPEGUS 64 mRCC 64 undetectable HCV RNA 64 tenofovir disoproxil fumarate 64 mycophenolate mofetil 64 achieved sustained virologic 64 mapatumumab 64 Traficet EN 64 amphotericin B 64 relapsed MM 64 infliximab 64 TMC# C# 64 oral allopurinol 64 lanthanum carbonate 64 mcg BID 64 doxorubicin HCl liposome injection 64 capecitabine 64 virologic response 64 #mg BID [001] 64 low dose cytarabine 64 standard chemotherapy regimen 64 Peginterferon Alfa 2a 64 ceftazidime 64 amprenavir 64 dose cytarabine 64 mg/m2 IV 64 mg m² 64 CHOP chemotherapy 64 TMC# [001] 64 mg/m2 64 log# IU mL 64 Pegasys peginterferon alfa 2a 64 FOLFIRI alone 64 #mg/m# [001] 64 doripenem 64 OADs 64 IFN alfa 64 divalproex sodium 64 fludarabine 64 goserelin 63 Raptiva r 63 plus methotrexate 63 comparator arm 63 REYATAZ r 63 PEGASYS ® 63 TMC# r 63 insulin detemir 63 tenofovir emtricitabine 63 valopicitabine 63 cytarabine 63 CIMZIA ™ 63 achieved ACR# 63 topotecan 63 mitomycin 63 lopinavir r arm 63 tolterodine ER 63 clopidogrel Plavix 63 IV bolus 63 refractory CLL 63 plus prednisone prednisolone 63 octreotide 63 mg dose 63 q8h 63 refractory NSCLC 63 BARACLUDE ® 63 q#h 63 voriconazole 63 etanercept 63 CCyR 63 HCV SPRINT 63 ceftriaxone 63 colesevelam HCl 63 dose regimens 63 sorafenib Nexavar 63 potent CYP#A# inhibitors 63 null responders 63 mg/m2/day 63 nilotinib 63 mcg QD 63 DMARDs 63 enfuvirtide 63 pegylated interferons 63 efavirenz EFV 63 noninferior 63 tocilizumab 63 tapentadol ER 63 sorafenib Nexavar ® 63 Perforomist Inhalation Solution 63 fluorouracil 63 bosentan 63 pegIFN 63 leucovorin 63 #mg QD [001] 63 estramustine 63 TDF FTC 63 cEVR 63 HBeAg seroconversion 63 Q2W 63 adalimumab Humira 63 rituximab 63 BENICAR 63 bortezomib 63 stavudine d4T 63 clopidogrel 63 5 FU leucovorin 63 fluconazole 63 nonresponders 63 FluCAM 63 cetuximab Erbitux ® 63 HBeAg positive 62 vancomycin 62 raltegravir 62 TNF inhibitor 62 cyclophosphamide 62 dose cohorts 62 docetaxel Taxotere 62 levofloxacin 62 oral levofloxacin 62 tolvaptan 62 CR nPR 62 abatacept 62 ribavirin USP 62 NPH insulin 62 gemcitabine cisplatin 62 #.#mg/dL 62 SCH # 62 bevacizumab 62 dosing cohorts 62 non inferiority 62 pomalidomide 62 VICTRELIS 62 clodronate 62 gemcitabine Gemzar 62 -#.# log# 62 PEGINTRON 62 3TC lamivudine Epivir 62 DOXIL 62 mg/m2 dose 62 zolmitriptan 62 imipenem 62 pioglitazone 62 ISENTRESS 62 neurologic progression 62 Irinotecan 62 virologic 62 subcutaneous injections 62 Darunavir 62 serum phosphorus 62 mCRC patients 62 relapsed multiple myeloma 62 metronidazole 62 INTELENCE 62 NOXAFIL 62 unfractionated heparin 62 #mg BID [003] 62 LANTUS R 62 fluticasone propionate 62 #mg/kg [002] 62 piperacillin tazobactam 62 null responder HCV 62 placebo dexamethasone 62 fosamprenavir 62 irinotecan 62 tipranavir r 62 randomized #:# 62 #mg dose [003] 62 mg tid 62 AZT zidovudine Retrovir 62 mg kg 62 tirofiban 62 bevacizumab Avastin ® 62 relapsed myeloma 62 doxorubicin docetaxel 62 virologic failure 62 μg kg 62 PEG Interferon alfa 62 cyclophosphamide methotrexate 62 cidofovir 62 adriamycin 62 infliximab monotherapy 62 achieved PASI 62 nicardipine 62 COPEGUS ribavirin 62 desvenlafaxine succinate 62 placebo p = 62 5 fluorouracil 62 ARIKACE 62 FUSILEV enhances 62 Copegus ® ribavirin 62 oral diclofenac 62 DMARD 62 HBeAg negative patients 62 interferon 62 trastuzumab Herceptin R 62 CAELYX 62 oral vancomycin 62 complete cytogenetic 62 invasive aspergillosis 62 median PFS 62 remission induction 62 ketoconazole 62 infusional 62 budesonide formoterol 62 pharmacologically active isomer 62 Copegus 62 metastatic renal cell carcinoma 62 FOLFOX4 alone 62 plus gemcitabine 62 tenofovir DF 62 ATACAND 62 Adalimumab 62 virus HCV protease inhibitor 62 MabCampath 62 induction regimen 62 mcg doses 62 budesonide 62 erlotinib Tarceva ® 62 alkylating agent 62 trabectedin 62 LEXIVA 62 nelfinavir 62 amrubicin 62 neoadjuvant 61 ZOLINZA 61 biologic DMARD 61 peginterferon alfa 2a Pegasys 61 dasatinib 61 docetaxel prednisone 61 CoFactor 61 partial remissions 61 beclomethasone dipropionate 61 FOSRENOL ® 61 anti TNF 61 methotrexate MTX 61 infliximab therapy 61 oral ribavirin 61 cetuximab Erbitux R 61 fluticasone furoate 61 olmesartan 61 disease modifying antirheumatic 61 ONGLYZA 61 folinic acid 61 FOLPI 61 COMBIVIR 61 BENICAR HCT 61 TNF antagonists 61 dexamethasone Decadron 61 ciclesonide 61 temozolomide 61 receiving VICTRELIS 61 NRTI 61 PEG INTRON 61 gout flares 61 XELOX 61 adefovir dipivoxil 61 SYMBICORT 61 febuxostat 61 EPIVIR 61 cyclophosphamide doxorubicin vincristine 61 PREZISTA rtv 61 dose regimen 61 octreotide LAR 61 INVANZ 61 interferon therapy 61 microgram kg 61 R# #mg BID 61 uric acid lowering 61 interferon alpha 61 dosed orally 61 glatiramer acetate 61 R ribavirin USP 61 thymalfasin 61 dose dexamethasone 61 metastatic GIST 61 5 Fluorouracil 61 relapsed refractory multiple myeloma 61 NNRTI 61 imatinib 61 tipranavir ritonavir 61 recurrent GBM 61 IIIa inhibitor 61 lenalidomide Revlimid R 61 refractory AML 61 Pegylated Interferon 61 interferon gamma 1b 61 ACE inhibitor ramipril 61 evaluable patients 61 Gemcitabine 61 VIRAMUNE 61 SPRYCEL ® 61 carboplatin 61 sorafenib tablets 61 etoposide 61 Pemetrexed 61 placebo 61 plus MTX 61 pegylated 61 noninferiority 61 anthracycline taxane 61 caspofungin 61 CorVue ™ 61 elotuzumab 61 bronchodilation 61 Elitek 61 log# reduction 61 lamivudine monotherapy 61 leukotriene receptor antagonist 61 intramuscularly 61 deferoxamine 61 KRAS mutations occur 61 beta2 agonist 61 ganciclovir 61 intravenous bolus 61 ALVESCO 61 Navelbine ® 61 dalteparin 61 Copegus ® 61 temsirolimus 61 belimumab 61 IU mL 61 #mg dose [001] 61 mg kg IV 61 cell lymphoma CTCL 61 omega interferon 61 relapsers 61 inhaled corticosteroid ICS 61 ibandronate 61 docetaxel Taxotere R 61 free survival PFS 61 doxorubicin cyclophosphamide 61 STELARA 61 sitagliptin 61 Taxotere R 61 chronic HCV infection 61 intravenously administered 61 mg d 61 nadolol 61 oxaliplatin Eloxatin 61 sirolimus eluting stent 61 splenectomized patients 61 timolol 61 cisplatin gemcitabine 61 olanzapine 61 Pegylated interferon 61 FASLODEX 61 metformin sulfonylurea 61 FOLFOX6 61 anti TNF alpha 61 montelukast 61 oblimersen 61 NATRECOR R 61 receiving INTRON 61 budesonide pMDI 61 3mg/kg 61 cytogenetic response 61 atazanavir 60 aripiprazole 60 PRT# 60 trastuzumab 60 TNF antagonist 60 edoxaban 60 8mg 60 highly emetogenic 60 mCi kg 60 sorafenib 60 paclitaxel Taxol 60 primary hypercholesterolemia 60 continuous intravenous infusion 60 mcg mL 60 treatment naive genotype 60 Apidra ® 60 zonisamide SR 60 eptifibatide 60 EGFR TKI 60 Engerix B 60 recurrent genital herpes 60 epoetin alfa 60 Tipranavir 60 DEB# 60 low dose dexamethasone 60 tenofovir Viread 60 tacrolimus ointment 60 salmeterol 60 anakinra 60 quetiapine 60 DMARD therapy 60 rt PA 60 RGT arm 60 pegfilgrastim 60 #mg/day [001] 60 naive HCV 60 pyrazinamide 60 MADRS score 60 titrated glipizide 60 PEG Intron ® 60 detectable HCV RNA 60 eszopiclone 60 pemetrexed 60 unfractionated heparin UFH 60 BARACLUDE R 60 anti rheumatic 60 antiretroviral naive 60 FEMALES SHOULD BE ADVISED 60 nortriptyline 60 ascending dose 60 gemcitabine carboplatin 60 risperidone 60 severe neutropenia 60 lopinavir 60 prostate cancer HRPC 60 long acting beta2 60 exenatide 60 ug dose 60 #μg [002] 60 teriflunomide 60 oxycodone CR 60 Ranolazine 60 TO AVOID PREGNANCY WHILE 60 fludarabine cyclophosphamide 60 citalopram 60 imatinib therapy 60 telbivudine 60 zidovudine lamivudine 60 metastatic RCC 60 alefacept 60 ascending doses 60 plasma HCV RNA 60 RLAI 60 metastatic HRPC 60 delayed onset CINV 60 #mg BID [002] 60 virological response 60 evaluable 60 chemotherapy gemcitabine 60 metformin HCl 60 angiotensin receptor blocker ARB 60 fluvastatin 60 PEG INTRON R 60 progression TTP 60 mometasone 60 indacaterol 60 lumiliximab 60 melphalan prednisone 60 ACR# response 60 elagolix 60 CRp 60 tinidazole 60 prucalopride 60 salmeterol inhalation powder 60 metformin monotherapy 60 Virologic 60 corticosteroid therapy 60 INFERGEN 60 evaluable subjects 60 Gemzar ® 60 tobramycin 60 BUPHENYL R sodium phenylbutyrate 60 N acetylcysteine 60 evaluating tivozanib 60 TAXOTERE R 60 INTEGRILIN R 60 μg doses 60 aflibercept 60 pegylated liposomal doxorubicin PLD 60 PROMACTA 60 zoledronic acid 60 CIMZIA TM certolizumab pegol 60 bolus dose 60 tamsulosin 60 ethambutol 60 Phase 2b study 60 REMICADE ® 60 Jevtana 60 NATRECOR ® 60 idraparinux 60 bevacizumab Avastin 60 VFEND 60 candesartan cilexetil 60 cetuximab 60 MCyR 60 valsartan amlodipine 60 FOLFOX regimen 60 inhaled fluticasone 60 xanthine oxidase inhibitor 60 methotrexate monotherapy 60 JANUVIA 60 oxymorphone ER 60 glycopyrrolate 60 infusional 5-FU/LV 60 acute gout flares 60 erlotinib 60 febrile neutropenia 60 Roche Pegasys 60 FOSRENOL R 60 aspirin heparin 60 dose cohort 60 PEGylated anti 60 TYGACIL 60 aflibercept VEGF Trap 59 fulvestrant 59 chemoradiation 59 irinotecan containing 59 telaprevir 59 Median PFS 59 prospectively defined 59 Vfend 59 morphometric vertebral fractures 59 canakinumab 59 MIRCERA 59 paclitaxel carboplatin 59 Tiotropium 59 TELINTRA 59 lamivudine 3TC 59 secondary efficacy endpoints 59 intravesical 59 NRTIs 59 postmenopausal osteoporotic women 59 amlodipine 59 temsirolimus Torisel ® 59 ARCOXIA 59 hour bronchodilation 59 paclitaxel Taxol R 59 rHuPH# 59 oral prodrug 59 YERVOY 59 taxane chemotherapy 59 palonosetron 59 #mg/#mg 59 pimecrolimus cream 59 invasive candidiasis 59 EPZICOM 59 tigecycline 59 Pharmacokinetic parameters 59 REVLIMID lenalidomide 59 Hycamtin ® 59 mcg 59 CR CRu 59 telaprevir pegylated interferon 59 beclomethasone 59 virological failure 59 VAPRISOL 59 certolizumab pegol 59 darunavir r 59 azilsartan medoxomil 59 BEACOPP 59 p = NS 59 tolerability 59 chemoradiotherapy 59 Folfox 59 galiximab 59 heavily pretreated patients 59 Paraplatin ® 59 Acetate Rectal Suppositories 59 XGEVA 59 DexaSite 59 #mg doses [002] 59 XIENCE V PROMUS Stent 59 zafirlukast 59 fluoropyrimidine 59 ertapenem 59 Platinol 59 ORENCIA ® 59 RG# [001] 59 sertraline 59 eplerenone 59 PEG Interferon lambda 59 Nasacort AQ 59 sunitinib malate 59 efavirenz Sustiva 59 dosing cohort 59 LTRA 59 SSRI SNRI 59 pioglitazone HCl 59 serum urate 59 μg 59 gefitinib 59 cytarabine daunorubicin 59 isoproterenol 59 plasma uric acid 59 thalidomide Thalomid 59 darunavir 59 metastatic hormone refractory 59 BROVANA 59 benazepril 59 AZILECT R 59 sipuleucel T 59 AzaSite Plus 59 solifenacin 59 lenalidomide 59 superficial bladder cancer 59 weekly subcutaneous injections 59 octreotide acetate 59 dacarbazine DTIC 59 AGILECT R 59 pharmacodynamics PD 59 mitoxantrone plus 59 oral ridaforolimus 59 bevacizumab Avastin R 59 #mg q8h 59 Camptosar ® 59 insulin lispro 59 aspirin clopidogrel 59 TYKERB 59 refractory gout 59 glucose lowering 59 risperidone Risperdal 59 LIALDA 59 biologic therapy 59 nevirapine Viramune 59 steroid dexamethasone 59 nodular partial response 59 ARB telmisartan 59 standard chemotherapy regimens 59 Lamivudine 59 riociguat 59 custirsen 59 oral prednisolone 59 ELOXATIN 59 lamivudine zidovudine 59 herpetic keratitis 59 triamcinolone 59 PREZISTA 59 HCV genotype 59 metastatic castration resistant 59 brand ciclesonide HFA 59 pertuzumab 59 levetiracetam 59 cyclophosphamide vincristine 59 alfa 2b 59 proton pump inhibitor PPI 59 mcg kg REBETOL 59 ritonavir boosted lopinavir 59 leukemia AML 59 INVEGA ® 59 cilostazol 59 basal insulin 59 EURIDIS 59 inhaled corticosteroid 59 risedronate 59 investigational protease inhibitor 59 IU ml 59 Chemophase 59 diuretic chlorthalidone 59 GnRH agonist 59 Platinol ® cisplatin 59 severe exacerbations 59 FOLPI regimen 59 aldosterone antagonist 59 ZYVOX 59 azithromycin 59 placebo controlled trials 59 Hepsera 59 dosing regimens 59 clomipramine 59 ARCALYST 59 fondaparinux 59 TLUS 59 tolterodine 59 ziprasidone 59 polymerase inhibitor 59 urate lowering therapy 59 Navelbine 59 sUA 59 Response Evaluation Criteria 59 rapid virologic response 59 irinotecan chemotherapy 59 fumarate 59 Lupuzor ™ 59 heavily pretreated 59 log# copies mL 59 miconazole 59 oxaliplatin 59 tolerability profile 59 HCV RNA 59 relapsed CLL 59 dosage regimen 59 APTIVUS ritonavir 59 pyridostigmine 59 nevirapine NVP 59 efalizumab 59 APRISO 59 microbiologically evaluable 59 atazanavir Reyataz 59 forodesine 59 genotypic resistance 59 rosuvastatin #mg 59 microg 59 Capecitabine 59 inactive placebo 59 efavirenz emtricitabine 59 acute coronary syndromes ACS 59 Tarceva TM 59 trimethoprim sulfamethoxazole 59 Lantus ® 59 Helicobacter pylori eradication 59 Bezielle 59 Tamibarotene 59 EMEND 59 serum HBV DNA 59 MIRAPEX 59 albinterferon alfa 2b 59 carvedilol 59 Omacetaxine mepesuccinate 59 baminercept 59 plus OBT 59 oral FTY# 59 abacavir sulfate lamivudine 59 achieved sustained virological 59 TORISEL 59 Sandostatin R 59 somatostatin analog 59 apremilast 59 icatibant 59 metastatic CRC 59 mGluR5 NAM 59 alteplase 59 imatinib mesylate Gleevec 59 MAGE A3 ASCI 59 Mg Uk 59 composite endpoint 59 migalastat HCl 59 RAPTIVA 59 pegylated IFN 59 TELCYTA 59 abciximab 58 zalutumumab 58 biphasic insulin aspart 58 #/#.# mcg 58 imatinib resistant 58 Anti TNF 58 bortezomib Velcade R 58 Bevacizumab 58 Noxafil 58 Rebetol 58 bolus injection 58 pharmacodynamic profile 58 sulphonylurea 58 L PPDS 58 blinded randomized placebo controlled 58 ara C 58 FROVA 58 intravitreal injection 58 Platinol ® 58 G CSF 58 dosage regimens 58 mg/# hr 58 REYATAZ R 58 #ug [001] 58 SCIg 58 hepatitis C genotype 58 indinavir 58 oral corticosteroids 58 drotrecogin alfa activated 58 RoACTEMRA 58 Lucentis monotherapy 58 liposome injection 58 mg eq 58 EVIZON 58 subcutaneous enoxaparin 58 TEAEs 58 Xeloda ® 58 rimonabant #mg 58 IRESSA 58 irinotecan doxorubicin oxaliplatin paclitaxel 58 chemoradiation therapy 58 liposomal formulation 58 sotalol 58 low dose ritonavir 58 APTIVUS R 58 adefovir treated 58 bezafibrate 58 EGFR expressing mCRC 58 telaprevir VX 58 subcutaneous dose 58 metformin 58 Aflibercept 58 RAPAFLO 58 randomized #:#:# 58 Viread Emtriva 58 corticosteroid dose 58 Linagliptin 58 NOXAFIL Oral Suspension 58 dose dose escalation 58 lacosamide 58 Cytoxan 58 aldosterone antagonists 58 subcutaneous doses 58 subcutaneous SC 58 CRESTOR #mg 58 immunomodulatory therapy 58 virologically 58 low dose Iluvien 58 eltrombopag 58 formoterol fumarate 58 GP IIb IIIa inhibitors 58 divalproex 58 treatment naïve genotype 58 achieved CCyR 58 mesalamine 58 efavirenz 58 amodiaquine 58 mg doses 58 complete cytogenetic response 58 HCTZ 58 complete remissions 58 bupivacaine 58 basiliximab 58 RECIST criteria 58 tiotropium bromide 58 maximally tolerated dose 58 mg kg belimumab 58 dapagliflozin plus 58 epoetin beta 58 de novo kidney transplant 58 Onbrez Breezhaler 58 aliskiren 58 epoprostenol 58 mometasone furoate 58 ACZ# 58 antiarrhythmic drug 58 glycoprotein IIb IIIa inhibitor 58 MMX mesalamine 58 intravenous IV infusion 58 cethromycin 58 cilengitide 58 CK # administered 58 lenalidomide dexamethasone 58 dacarbazine chemotherapy 58 Secondary endpoints include 58 esomeprazole 58 Fludarabine 58 granisetron 58 ancrod 58 Trastuzumab 58 HBeAg + 58 reteplase 58 flutamide 58 β blockers 58 ALT elevations 58 patients evaluable 58 iniparib 58 ARIXTRA 58 hypercalcemia 58 Aztreonam lysine 58 dosing intervals